Position
Fidelity in Collegium Pharmaceutical, Inc
Back to the book · All holders of COLL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.14M$1.89 → $2.28
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.91M | $6.79M | — | — | — | 0.0% |
| Q1 2026 | 2.92M | $5.5M | $1.89 | −$1.3M | $12.4K | 0.0% |
| Q2 2026 | 2.92M | $6.65M | $2.28 | $1.14M | $13.3K | 0.0% |